Casdin Capital, LLC 4 D Molecular Therapeutics, Inc. Transaction History
Casdin Capital, LLC
- $1.29 Billion
- Q3 2024
A detailed history of Casdin Capital, LLC transactions in 4 D Molecular Therapeutics, Inc. stock. As of the latest transaction made, Casdin Capital, LLC holds 1,150,000 shares of FDMT stock, worth $9.57 Million. This represents 0.97% of its overall portfolio holdings.
Number of Shares
1,150,000
Previous 800,000
43.75%
Holding current value
$9.57 Million
Previous $16.8 Million
25.97%
% of portfolio
0.97%
Previous 1.45%
Shares
10 transactions
Others Institutions Holding FDMT
# of Institutions
144Shares Held
57.7MCall Options Held
137KPut Options Held
111K-
Bvf Inc San Francisco, CA7.38MShares$61.4 Million2.54% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.1MShares$42.4 Million0.77% of portfolio
-
Black Rock Inc. New York, NY4.9MShares$40.7 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY4.4MShares$36.6 Million4.93% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.1MShares$34.1 Million1.63% of portfolio
About 4D Molecular Therapeutics, Inc.
- Ticker FDMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,382,400
- Market Cap $269M
- Description
- 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...